Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$2.88 - $4.33 $54,092 - $81,326
-18,782 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$2.89 - $4.32 $16,825 - $25,151
5,822 Added 44.92%
18,782 $73,000
Q4 2019

Feb 07, 2020

BUY
$4.28 - $5.95 $856 - $1,190
200 Added 1.57%
12,960 $61,000
Q3 2019

Oct 31, 2019

SELL
$2.97 - $6.42 $79,854 - $172,614
-26,887 Reduced 67.82%
12,760 $72,000
Q2 2019

Aug 09, 2019

BUY
$2.93 - $3.6 $4,403 - $5,410
1,503 Added 3.94%
39,647 $124,000
Q1 2019

Apr 24, 2019

SELL
$2.19 - $3.45 $1,112 - $1,752
-508 Reduced 1.31%
38,144 $124,000
Q4 2018

Jan 29, 2019

BUY
$1.7 - $2.88 $2,866 - $4,855
1,686 Added 4.56%
38,652 $70,000
Q2 2018

Aug 10, 2018

BUY
$1.88 - $2.41 $69,496 - $89,088
36,966 New
36,966 $74,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.